Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Genomic Pathways and Potential Therapeutic Targets in Pediatric Burkitt Lymphoma (PBL): A Children's Oncology Group Report

Mitchell S. Cairo, MD, Nancy Day, Ph.D., Stanton Goldman, MD, Warren G. Sanger, PhD, Lauren Harrison, RN, MSN, Megan S. Lim, MD, PhD, Rodney R. Miles, MD, PhD, Sherrie L. Perkins, MD, PhD

Blood (2011) 118 (21): 1587.

https://doi.org/10.1182/blood.V118.21.1587.1587

Published: 2011

Journal Articles

Global Proteomic Profiling of Endemic Versus Sporadic Epstein-Barr Virus (EBV) Positive Burkitt Lymphoma (BL).

Nader El-Mallawany, MD, Janet Ayello, MS, MT, Nancy Day, Ph.D., Carmella van de Ven, MS, Kevin P Conlon, Damian Fermin, Venkatesha Basrur, Kojo S.J. Elenitoba-Johnson, Megan S Lim, MD, PhD, Mitchell S. Cairo, MD

Blood (2009) 114 (22): 4779.

https://doi.org/10.1182/blood.V114.22.4779.4779

Published: 2009

Journal Articles

DLEU1 siRNA Gene Knockdown IN BURKITT LYMPHOMA (bl) IS ASSOCIATED with A SIGNIFICANT Decrease IN Cyclophosphamide (CY) and/or Rituximab Induced Apoptosis: Mechanism of Drug Resistance in BL.

Nancy Day, Ph.D., Janet Ayello, MS, MT, Carmella van de Ven, MA, Megan S Lim, MD, PhD, Sherrie L. Perkins, MD, PhD, Warren Sanger, PhD, Lauren Harrison, RN, Stanton Goldman, MD, Mitchell S. Cairo, MD

Blood (2009) 114 (22): 1928.

https://doi.org/10.1182/blood.V114.22.1928.1928

Published: 2009

Journal Articles

Genetic Engineering and Significant Ex-Vivo Expansion of Cord Blood Natural Killer Cells: Implications for Post-Transplant Adoptive Cellular Immunotherapy

Jessica Hochberg, MD, Brenton Mar, MD, Janet Ayello, MS, MT, Nancy Day, Carmella van de Ven, Angela Ricci, Lalit Gurnani, Evan Cairo, Dario Campana, MD., PhD, Mitchell S. Cairo

Blood (2008) 112 (11): 209.

https://doi.org/10.1182/blood.V112.11.209.209

Published: 2008

Journal Articles

Inhibition of DLEU1 Following siRNA Transfection in Burkett’s Lymphoma (BL): Implication for Tumor Repressor Role of DLEU1 in C-Myc-Activated BL Lymphomagenesis

Nancy Day, Janet Ayello, MS, MT, Ian Waxman, MD, Evan Shereck, Catherine McGuinn, MD, Carmella van de Ven, MS, Megan S Lim, Sherrie L. Perkins, MD, PhD, Mitchell S. Cairo, MD

Blood (2008) 112 (11): 5335.

https://doi.org/10.1182/blood.V112.11.5335.5335

Published: 2008

Journal Articles

NK Receptor (NKR)-Mediated Signaling Pathways in Cord Blood (CB) CD56 dim Versus Peripheral Blood (PB) CD56 dim NK Cells: Implication for Immaturity in Cord Blood NK CD56 dim Innate Immunity

Nancy Day, Evan Shereck, MD, Janet Ayello, MS, MT, Catherine McGuinn, Prakash Satwani, Duane Lewis, Carmella van de Ven, Ronald J. Wapner, MD, Megan S Lim, Mitchell S. Cairo, MD

Blood (2008) 112 (11): 4897.

https://doi.org/10.1182/blood.V112.11.4897.4897

Published: 2008

Journal Articles

Correlation Between Increases in Apoptosis in Primary Mediastinal B-Cell Lymphoma (PMBL) and NF-κB Pathway Blockade: Bortezomib (BTZ), Small Molecule IKK Inhibitor ML120B and Combination Therapy Significantly Decrease NF-κB Family Member Protein Activation

Ian Waxman, MD, Dongxu Xie, Carmella van de Ven, Janet Ayello, MS, MT, Nancy Day, Megan S Lim, Sherrie L. Perkins, MD, PhD, Mitchell S. Cairo, MD

Blood (2008) 112 (11): 4983.

https://doi.org/10.1182/blood.V112.11.4983.4983

Published: 2008

Journal Articles

Immunophenotypic and Proteomic Characterization of Cord Blood (CB) CD56 dim Versus Peripheral Blood (PB) CD56 dim NK Cells.

Evan Shereck, MD, Nancy Day, PhD, Catherine McGuinn, MD, Prakash Satwani, MD, Carmella van de Ven, MA, Janet Ayello, MS, David Crockett, MS, Ronald J. Wapner, MD, Kojo Elenitoba-Johnson, MD, Megan Lim, MD, PhD, Mitchell S. Cairo, MD

Blood (2007) 110 (11): 3879.

https://doi.org/10.1182/blood.V110.11.3879.3879

Published: 2007

Journal Articles

Peripheral Blood (PB) CD56 bright and CD56 dim Do Not Exhibit Differences in NKR Expression Compared to Their Cord Blood (CB) Counterparts: CB CD56 dim May Represent an Intermediary between CB CD56 bright and PB CD56 dim .

Evan Shereck, MD, Prakash Satwani, MD, Carmella van de Ven, Janet Ayello, Ronald J. Wapner, MD, Nancy Day, PhD, Hong Jiang, PhD, Mitchell S. Cairo, MD

Blood (2006) 108 (11): 5155.

https://doi.org/10.1182/blood.V108.11.5155.5155

Published: 2006

NARROW

Genomic Pathways and Potential Therapeutic Targets in Pediatric Burkitt Lymphoma (PBL): A Children's Oncology Group Report

Global Proteomic Profiling of Endemic Versus Sporadic Epstein-Barr Virus (EBV) Positive Burkitt Lymphoma (BL).

DLEU1 siRNA Gene Knockdown IN BURKITT LYMPHOMA (bl) IS ASSOCIATED with A SIGNIFICANT Decrease IN Cyclophosphamide (CY) and/or Rituximab Induced Apoptosis: Mechanism of Drug Resistance in BL.

Genetic Engineering and Significant Ex-Vivo Expansion of Cord Blood Natural Killer Cells: Implications for Post-Transplant Adoptive Cellular Immunotherapy

Inhibition of DLEU1 Following siRNA Transfection in Burkett’s Lymphoma (BL): Implication for Tumor Repressor Role of DLEU1 in C-Myc-Activated BL Lymphomagenesis

NK Receptor (NKR)-Mediated Signaling Pathways in Cord Blood (CB) CD56 dim Versus Peripheral Blood (PB) CD56 dim NK Cells: Implication for Immaturity in Cord Blood NK CD56 dim Innate Immunity

Correlation Between Increases in Apoptosis in Primary Mediastinal B-Cell Lymphoma (PMBL) and NF-κB Pathway Blockade: Bortezomib (BTZ), Small Molecule IKK Inhibitor ML120B and Combination Therapy Significantly Decrease NF-κB Family Member Protein Activation

Immunophenotypic and Proteomic Characterization of Cord Blood (CB) CD56 dim Versus Peripheral Blood (PB) CD56 dim NK Cells.

Peripheral Blood (PB) CD56 bright and CD56 dim Do Not Exhibit Differences in NKR Expression Compared to Their Cord Blood (CB) Counterparts: CB CD56 dim May Represent an Intermediary between CB CD56 bright and PB CD56 dim .

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only